logo
From total dependence to classroom confidence: Inspiring recovery journey of young Nasser at Salma Rehabilitation Hospital

From total dependence to classroom confidence: Inspiring recovery journey of young Nasser at Salma Rehabilitation Hospital

Al Etihad09-07-2025
9 July 2025 16:14
ABU DHABI (ALETIHAD)SEHA, a subsidiary of PureHealth, the largest healthcare group in the Middle East, has announced the remarkable progress of a three-year-old patient, Nasser, at Salma Rehabilitation Hospital. Nasser was diagnosed with a spinal cord injury and required complete support for all activities of daily living upon his arrival. He had limited movement, particularly in his left upper limb, and minimal verbal communication.Nasser's rehabilitation journey reflects the significant difference that multidisciplinary care can make in paediatric recovery. From the moment he was admitted to Salma Rehabilitation Hospital, he received comprehensive care from a specialised team including physicians, physiotherapists, occupational therapists, speech and language therapists, and educators.Dr. Ashraf Elbatal, Consultant Pediatrician-Clinical Lead, Salma Rehabilitation Hospital, stated: 'Nasser, diagnosed with genetic muscular conditions and reliant on mechanical ventilation 24/7, continues to inspire us. Despite the complexity of his case, he remains full of life, supported by a clinical plan tailored to manage his symptoms and improve his quality of life.'Upon admission, Nasser exhibited muscle weakness, lacked head and trunk control, and was entirely dependent for mobility and self-care. Through intensive therapy, his physical abilities began to improve. He developed better control of his head and trunk, and now sits upright with supervision, uses a wheelchair independently, and can briefly stand with support.Kristopher B. Bantilan, Physiotherapist, commented: 'Nasser's cheerful disposition and resilience were evident during therapy. Each session reflected his growing strength, particularly in trunk control, and his enthusiasm motivated all who worked with him.'Occupational therapy contributed significantly to Nasser's independence. Previously fully dependent, he now feeds himself using both hands. 'This progress brings him closer to his personal goal of attending school,' said Deidre Diane Karfor, Occupational Therapist. 'Nasser can now sit with his peers at break time, feeding himself independently.'His communication also improved significantly. Initially limited to minimal Arabic and struggling with feeding, Nasser has progressed in both oral motor function and language skills. Targeted therapy enhanced his Arabic and introduced English to prepare him for school. Feeding therapy addressed sensory aversions, expanded his diet, and promoted healthy weight gain.Raadiya Rafiek Mohamed, Speech and Language Therapist, noted: 'Nasser's language acquisition has been outstanding. From using a single word to now communicating fluently in both Arabic and English, he has shown extraordinary engagement. His feeding milestones have likewise improved, with a broader acceptance of textures and flavours.'Salma's educational team identified Nasser's academic potential and integrated him into formal schooling. Jonathan Gianan, Education and Recreation Lead, stated: 'Developing Nasser's Individualised Education Plan was a milestone towards his reintegration. At Salma, our commitment to inclusion and quality of life remains paramount.'
Nasser's story highlights the transformative power of interdisciplinary paediatric rehabilitation. From total dependency, he has become a confident and communicative young child, demonstrating resilience, engagement, and remarkable progress. With continued support, Nasser's future remains full of promise.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FDA recommends restricting 7-OH opioid products found in some vapes
FDA recommends restricting 7-OH opioid products found in some vapes

Al Etihad

timean hour ago

  • Al Etihad

FDA recommends restricting 7-OH opioid products found in some vapes

29 July 2025 19:44 ABU DHABI (ALETIHAD)The US Food and Drug Administration has recommended a scheduling action to control certain 7-hydroxymitragynine (also known as 7-OH1) products that are commonly found in vapes. The FDA is specifically targeting 7-OH, a concentrated byproduct of the kratom plant that is increasingly recognised as having potential for abuse because of its ability to bind to opioid receptors. 'Today, we're taking action on 7-OH as a critical step in the fight against opioid addiction,' said HHS Secretary Robert F. Kennedy, Jr.'We will protect the health of our nation's youth as we advance our mission to Make America Healthy Again.'This recommendation follows a thorough medical and scientific analysis by the FDA, and is one of several efforts to address the agency's concerns around the growing availability and use of 7-OH opioid products. There are no FDA-approved 7-OH drugs, 7-OH is not lawful in dietary supplements and 7-OH cannot be lawfully added to conventional foods. 'Vape stores are popping up in every neighborhood in America, and many are selling addictive products like concentrated 7-OH. After the last wave of the opioid epidemic, we cannot get caught flat-footed again,' said FDA Commissioner Marty Makary, M.D., M.P.H.'7-OH is an opioid that can be more potent than morphine. We need regulation and public education to prevent another wave of the opioid epidemic.'The FDA is particularly concerned with the growing market of 7-OH products that may be especially appealing to children and teenagers, such as fruit-flavored gummies and ice cream cones. These products may not be clearly or accurately labeled as to their 7-OH content and are sometimes disguised or marketed as kratom. The FDA has issued a letter to health care professionals, and has warned consumers about the risks associated with 7-OH products. Source: Aletihad - Abu Dhabi

We have entered third stage of famine in Gaza: Director of Al-Shifa Medical Complex
We have entered third stage of famine in Gaza: Director of Al-Shifa Medical Complex

Middle East Eye

time2 hours ago

  • Middle East Eye

We have entered third stage of famine in Gaza: Director of Al-Shifa Medical Complex

"I believe we have entered the third stage of famine in the Gaza Strip. Malnutrition is claiming the lives of our patients despite our efforts to save them," Dr Mohammed Abu Salmiya, the director of Al-Shifa Medical Complex, has told Al Jazeera Arabic. Israel has killed more than 60,000 Palestinians in Gaza, the health ministry has said. Israeli forces have killed at least 62 people across Gaza since dawn, including 19 aid seekers.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store